Lucid Diagnostics Inc. - Common Stock

Lucid Diagnostics Inc. - Common Stock

Share · US54948X1090 · LUCD (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Lucid Diagnostics Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
0
0
0
No Price
28.04.2026 22:49
Current Prices from Lucid Diagnostics Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
LUCD
USD
28.04.2026 22:49
1,09 USD
0,03 USD
+2,83 %
IEXG: IEX
IEX
LUCD
USD
28.04.2026 19:59
1,05 USD
-0,01 USD
-0,94 %
Share Float & Liquidity
Free Float 37,12 %
Shares Float 37,97 M
Shares Outstanding 102,3 M
Company Profile for Lucid Diagnostics Inc. - Common Stock Share
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Company Data

Name Lucid Diagnostics Inc. - Common Stock
Company Lucid Diagnostics Inc.
Symbol LUCD
Website https://www.luciddx.com
Primary Exchange XNAS NASDAQ
ISIN US54948X1090
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Lishan Aklog
Market Capitalization 106 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address One Grand Central Place, 10165 New York City
IPO Date 2021-10-14

Ticker Symbols

Name Symbol
NASDAQ LUCD
More Shares
Investors who hold Lucid Diagnostics Inc. - Common Stock also have the following shares in their portfolio:
ASIAN DEV.BK 21/27 MTN
ASIAN DEV.BK 21/27 MTN Bond
GraniteShares 3x Long Royal Dutch Shell Daily ETC
GraniteShares 3x Long Royal Dutch Shell Daily ETC ETF